Clinical Trials Sponsored by Neoplas Med

Total 7944 results

EMD Serono

Completed

Prospective Observational Long-term Safety Registry of Multiple Sclerosis Participants Who Have Participated in Cladribine Clinical Trials (PREMIERE)

Multiple Sclerosis

United States
Medy-Tox

Completed

Efficacy and Safety Study of MT10107 in the Treatment of Glabella Line

Glabellar Frown Lines
Medy-Tox

Completed

MEDITOXIN® Treatment in Subjects With Post-Stroke Upper Limb Spasticity

Spasticity, Muscle
Medy-Tox

Completed

Efficacy and Safety of MEDITOXIN® in Cervical Dystonia (CD Phase III)

Cervical Dystonia
Medy-Tox

Completed

Efficacy and Safety Study of MT10109L in the Treatment of Glabella Line(Including a Preliminary Study to Evaluate Safety of MT10109L)

Glabella Line Severity

Korea, Republic of
Medy-Tox

Completed

Medytoxin® Treatment in Patients With Benign Masseteric Hypertrophy

Hypertrophy of Masseter Muscle

Korea, Republic of
Medy-Tox

Completed

Anhidrotic Area and Safety of MEDITOXIN in Healthy Male Valunteers

Hyperhidrosis | Anhidrotic Area

Korea, Republic of
Medy-Tox

Completed

Efficacy and Safety of Potenfill for Temporary Penile Enhancement

Penile Enhancement

Korea, Republic of
EMD Serono

Completed

First-in-Human Dose Escalation Trial in Subjects With Advanced Malignancies

Solid Tumor

United States
EMD Serono

Completed

Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients

HIV Infections | Lipodystrophy

United States, Canada
EMD Serono

Completed

Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction

Anovulation

United States
EMD Serono

Withdrawn

Determine if Either of 2 Doses of Study Drug Given With a Low-dose of Cyclophosphamide After a Complete or Partial Response to a Platinum-based Second-line Therapy in Women With Recurrent Ovarian Carcinoma Results in a Longer Time to Progression When Compared to the First Time to Progression.

Ovarian Cancer
Medy-Tox

Completed

Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lines

Glabellar Lines
Medy-Tox

Completed

Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Essential Blepharospasm

Essential Blepharospasm
EMD Serono

Terminated

RESOunD: REbif Satisfaction On Discontinuing Oral Dimethyl Fumarate (RESOunD)

Multiple Sclerosis

United States
EMD Serono

Terminated

Sym004 in Subjects With Stage IV Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States, Germany
EMD Serono

Terminated

Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)

Relapsing Remitting Multiple Sclerosis

United States, Croatia, Bulgaria, Czech Republic, Italy, Mexico, Russian Federation, South Africa, Spain, Turkey, Hungary, Poland, Ukraine, Finland, United Kingdom, Greece, Serbia
Medy-Tox

Completed

Efficacy and Safety Evaluation Study of Neuramis® Deep Lidocaine in Correction of Nasolabial Fold

Nasolabial Fold

Korea, Republic of
Meda Pharmaceuticals

Completed

A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis

Perennial Allergic Rhinitis

United States
EMD Serono

Terminated

Adherence Trial With MS LifeLines ® Services

Multiple Sclerosis | Relapsing-Remitting

United States
Medy-Tox

Completed

Study for Determine the Safety and Efficacy of Clostridium Botulinum Toxin Type A in Subjects With Cervical Dystonia

Cervical Dystonia

Australia
EMD Serono

Terminated

STRIDE - STimulating Immune Response In aDvanced brEast Cancer (STRIDE)

Breast Cancer

Czech Republic, Korea, Republic of, Russian Federation, South Africa, Germany, Slovakia, Austria, United States, Belgium, Poland, Israel, Australia
EMD Serono

Completed

The REbif® vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial (REGARD-PGx)

Relapsing Multiple Sclerosis

United States
EMD Serono

Completed

A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS) (CLARITY)

Multiple Sclerosis, Relapsing-Remitting
EMD Serono

Completed

Prospective, Open-label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients (RENEW)

Multiple Sclerosis

United States
EMD Serono

Completed

EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide

Colorectal Cancer | Ovarian Cancer | Prostate Cancer | Carcinoma, Non-small-cell Lung

United States, Switzerland
EMD Serono

Terminated

First-in-Man, Dose-escalation Trial of c-Met Kinase Inhibitor EMD 1204831 in Subjects With Advanced Solid Tumors

Solid Tumors

United States
EMD Serono

Completed

ATS-1 Needle Free Injection Device Study-a Device for Administering r-hGH (Saizen) to Treat Growth Hormone Deficiency

Healthy
EMD Serono

Completed

A Prospective Study to Evaluate the Addition of Subcutaneous Recombinant Human-Luteinizing Hormone With Recombinant Human-Follicle Stimulating Hormone on Follicular Development in Women Undergoing Ovarian Stimulation for Assisted Reproductive Technologies

Infertility | Ovarian Stimulation
EMD Serono

Terminated

Saizen® Solution for Injection Adult Growth Hormone Deficiency (GHD) Immunogenicity Study

Growth Hormone Deficiency (GHD)

United States
EMD Serono

Completed

Cool.Click™ Adolescent Transition Study: Study of Saizen® in Subjects With Childhood-onset Growth Hormone Deficiency

Pituitary Dwarfism | Childhood-onset Growth Hormone Deficiency

United States
EMD Serono

Completed

Rebif New Formulation (RNF) Quality of Life (QOL) Study (RebiQoL)

Relapsing Multiple Sclerosis

United States
EMD Serono

Completed

Safety and Efficacy Study of Serostim® Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome

Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome

United States, Canada
EMD Serono

Completed

An Open Label, Canadian Phase IIIb Study With Ovidrel in Ovulation Induction (OI) and Assisted Reproductive Technique (ART)

Infertility | Ovulation Induction
Meda Pharmaceuticals

Completed

A Study Evaluating the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

Seasonal Allergic Rhinitis

United States
Meda Pharmaceuticals

Completed

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

Seasonal Allergic Rhinitis

United States
Meda Pharmaceuticals

Completed

A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis

Perennial Allergic Rhinitis

United States
Meda Pharmaceuticals

Completed

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies

Perennial Allergic Rhinitis

United States
Medy-Tox

Completed

MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL)

Lateral Canthal Lines | Glabellar Lines

United States, Russian Federation, Germany, Canada, Belgium, United Kingdom
Medy-Tox

Completed

Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines

Glabellar Frown Lines

Australia
Medy-Tox

Completed

MT10109L in the Treatment of Lateral Canthal Lines

Lateral Canthal Lines

United States, Russian Federation, United Kingdom
Medy-Tox

Completed

MT10109L in the Treatment of Glabellar Lines

Glabellar Lines

United States, Belgium, Russian Federation
Medy-Tox

Completed

MT10109L in the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar Lines

Lateral Canthal Lines | Glabellar Lines

United States, Germany, Canada
Medy-Tox

Completed

MT10109L in the Treatment of Glabellar Lines (GL) With or Without Concurrent Treatment of Lateral Canthal Lines (LCL)

Lateral Canthal Lines | Glabellar Lines

United States, Germany, Canada, United Kingdom
Medy-Tox

Completed

CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase1)

Muscle Spasticity

Korea, Republic of
Medy-Tox

Completed

CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase3)

Muscle Spasticity

Korea, Republic of
Medy-Tox

Completed

Neuramis® Volume Lidocaine for Volume Augmentation in the Mid-Face

Mid Face Volume Loss

China
Medy-Tox

Completed

Long-term Safety and Efficacy of MEDITOXIN® in Treatment Glabellar Lines

Glabellar Frown Lines

Korea, Republic of
Medy-Tox

Completed

Pharmacodynamic and Safety of MT10107(Botulinum Type A Neurotoxin) in Comparison to BOTOX®

Healthy Volunteers

Korea, Republic of
Medy-Tox

Completed

The Efficacy and Safety of CUNOX® in Patients With Moderate to Severe Glabellar Lines

Glabellar Frown Lines

Russian Federation

3

Subscribe